5-(Pyridin-2-yl)pyrimidine

Catalog No.: 
ACMBRN028
CAS No.: 
64858-29-3
Molecular Formula: 
C9H7N3
Molecular Weight: 
157.18
5-(Pyridin-2-yl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$1742.001 week1 week

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Pyridin-2-yl)pyrimidine
IUPAC Name5-(pyridin-2-yl)pyrimidine
MDL No.MFCD13152524
Molecular FormulaC9H7N3
Molecular Weight157.18
SMILESC1=CN=C(C=C1)C1=CN=CN=C1
InChI KeyNRGNZMZNCZZXII-UHFFFAOYSA-N
SynonymPyrimidine, 5-(2-pyridinyl)- (9CI);5-(Pyridin-2-yl)pyrimidine;5-(pyridine-2-yl)pyrimidine;Pyrimidine, 5-(2-pyridinyl)-
CAS No.64858-29-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMBRN028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFHXR638 route compound structure diagram
    ACFHXR638109-04-6In Stock
  2. Plus
  3. ACVKLZ063 route compound structure diagram
    ACVKLZ063109299-78-7In Stock
  4. Then
  5. ACMBRN028 route product structure diagram
    ACMBRN02864858-29-3
Inquiry

2. ACMBRN028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSAIW213 route compound structure diagram
    ACSAIW2134595-59-9In Stock
  2. Plus
  3. ACOJZD165 route compound structure diagram
    ACOJZD165197958-29-5In Stock
  4. Then
  5. ACMBRN028 route product structure diagram
    ACMBRN02864858-29-3
Inquiry

3. ACMBRN028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSAIW213 route compound structure diagram
    ACSAIW2134595-59-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMBRN028 route product structure diagram
    ACMBRN02864858-29-3
Inquiry

Comments (0)